TP53 mutations are found in approximately half of all human cancers. They contribute to tumorigenesis by allowing cells to evade apoptosis, continue proliferating despite DNA damage, and resist therapeutic interventions. Histologically, tumors with TP53 mutations often present with increased cellular atypia and diverse morphological features.
